Irritable bowel syndrome therapy in Vietnam with probiotic enterococci

Author:

Ermolenko E. I.1ORCID,Kotyleva M. P.2ORCID,Tsapieva A. N.2ORCID,Karaseva A. B.2,Bui Thi Lan An3,Suvorov A. N.4ORCID

Affiliation:

1. I. I. Mechnikov Northwestern State Medical University

2. Federal State Budgetary Scientifi c Institution “Institute of Experimental Medicine” (FSBRI “IEM”)

3. Vietnam-Russia Tropical Centr

4. Federal State Budgetary Scientifi c Institution “Institute of Experimental Medicine” (FSBRI “IEM”); Saint Petersburg State University

Abstract

In this work, we compared composition of the intestinal microbiota of healthy volunteers and patients with irritable bowel syndrome (IBS) in Hanoi residents before and after therapy with a probiotic starter culture based on the bacteriocinogenic strain Enterococcus faecium L3 (L3), which is successfully used to correct dysbiosis and treat IBS in Russia.In IBS patients (IBS group) α-diversity was higher than in the control group (Healthy) and in IBS patients after probiotic therapy (IBS + L3 group). Phylogenetic analysis of the studied samples refl ected the division of the studied communities into 2 clusters, one of which grouped samples, mainly taken for IBS before therapy. Principal component analysis (PCoA) showed that most of the samples from the IBS group are located on the graph in a separate sector, far from the adjacent IBS + L3 and Нealthy samples.A study of the microbiome of Vietnamese patients with IBS after taking probiotic at the level of types (phyls) revealed a tendency towards an increase in the representation of Firmicutes. The introduction of L3 led to an increase in the population of members of the family Lachnospiraceae, such as butyrate- producing Roseburia and acetate-producing Blautia. At the same time, the percentage of staphylococci and bacteria belonging to the Enterobacteriaceae family was decreased. In addition to positive changes in the functioning of the gastrointestinal tract, revealed on the basis of clinical data, the features of the intestinal microbiota of IBS residents of Hanoi compared with healthy volunteers and in the same patients after probiotic therapy were revealed by metagenomic analysis of 16S rRNA genes. Positive shifts in the intestinal microbiome of IBS patients in Vietnam after therapy with a probiotic starter culture based on L3 do not fundamentally diff er from the previously described eff ects noted by the authors when using this probiotic in Russia, which creates the preconditions for expanding the possibility of its use in the Asian region.

Publisher

LLC Global Media Technology

Subject

Gastroenterology,Hepatology

Reference40 articles.

1. Solov’eva O.I., Simanenkov V. I., Suvorov A. N., Ermolenko E. I., Shumihina I. A., Svirido D. A. The use of probiotics and autoprobiotics in the treatment of irritable bowel syndrome. Experimental and Clinical Gastroenterology. 2017;(7):115–120. (In Russ.)

2. Ivashkin V.T., Shelygin Ju.A., Baranskaja E. K., et al. Russian Journal of Gastroenterology, Hepatology, Coloproctology. Clinical guidelines for the diagnosis and treatment of patients with irritable bowel syndrome. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2014; 24(2):92–101. (In Russ.)

3. Xiong L. S., Chen M. H., Chen H. X., Xu A. G., Wang W. A., Hu P. J. A population-based epidemiologic study of irritable bowel syndrome in South China: stratifi ed randomized study by cluster sampling. Aliment. Pharmacol. Ther. 2004. Vol.19, pp.1217–1224. doi:10.1111/j.1365–2036.2004.01939.

4. Chey W. D., Kurlander J., Eswaran, S. Irritable bowel syndrome: aclinical review. JAMA. 2015. Vol. 313, pp.949–958. doi:10.1001/jama.2015.0954.

5. Zhuang X., Tian Z., Li L., Zeng Z., Chen M., Xiong L. Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome. Front. Microbiol. 2018. Vol. 25; 9:1600. doi:10.3389/fmicb.2018.01600. eCollection 2018.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3